Drugs / [18F]F-RESCA-EPCD6
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07026110 | Dec 2024 → Oct 2026 expected | lung cancer | RenJi Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]F-RESCA-EPCD6 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07026110 ↗ |